scispace - formally typeset
J

Jens D. Mikkelsen

Researcher at Copenhagen University Hospital

Publications -  300
Citations -  13178

Jens D. Mikkelsen is an academic researcher from Copenhagen University Hospital. The author has contributed to research in topics: Hypothalamus & Receptor. The author has an hindex of 60, co-authored 293 publications receiving 12439 citations. Previous affiliations of Jens D. Mikkelsen include University of Copenhagen & Panum Institute.

Papers
More filters
Journal ArticleDOI

Distribution of glp-1 binding sites in the rat brain : evidence that exendin-4 is a ligand of brain glp-1 binding sites

TL;DR: The biochemical data support the idea that the central GLP‐1 receptor resembles the peripheral GLP-1 receptor, and the presence of GLp‐1 binding sites in the circumventricular organs suggests that these may be receptors which act as the target for both peripheral blood‐borne GLP­1 and GLP•1 in the nervous system.
Journal ArticleDOI

Modulation of anxiety circuits by serotonergic systems.

TL;DR: The possibility that the regulation of anxiety states and anxiety-related behavior by serotonergic systems is dependent on a specific, topographically organized mesolimbocorticalserotonergic system that originates in the mid-rostrocaudal and caudal parts of the dorsal raphe nucleus is explored.
Journal ArticleDOI

Pituitary Adenylate Cyclase-Activating Peptide (PACAP) in the Retinohypothalamic Tract: A Potential Daytime Regulator of the Biological Clock

TL;DR: A new signaling pathway by which the RHT may regulate circadian timing in the daytime as well, through a cAMP-dependent pathway, which could be blocked by a specific cAMP antagonist, Rp-cAMPS.
Journal ArticleDOI

Kisspeptin Mediates the Photoperiodic Control of Reproduction in Hamsters

TL;DR: It is proposed that photoperiod, via melatonin, modulates KiSS-1 signaling to drive the reproductive axis, consistent with a role of Ki SS1/GPR54 in the seasonal control of reproduction.
Journal ArticleDOI

Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors.

TL;DR: The present study is the first to demonstrate that NPY possesses anticonvulsant activity and suggests that agonists acting at Y5-like receptors may constitute a novel group of drugs in antiepileptic therapy.